These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31370746)

  • 41. High Seroprevalence of Hepatitis C Virus Among Cisgender Women Who Exchange Sex in the Seattle, Washington Area.
    Barry MP; Corcorran MA; Tsui JI; Moreno C; Buskin SE; Guthrie BL; Glick SN
    Subst Use Addctn J; 2024 Jan; 45(1):81-90. PubMed ID: 38258855
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
    Burt RD; Hagan H; Garfein RS; Sabin K; Weinbaum C; Thiede H
    J Urban Health; 2007 May; 84(3):436-54. PubMed ID: 17356901
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The seroprevalence of HCV among injecting drug users in the years 2004-2008 in Slovakia].
    Gazdíková K; Gazdík F; Kajaba I; Hučková D; Okruhlica L; Farkašová D
    Vnitr Lek; 2012 Mar; 58(3):179-82. PubMed ID: 22486282
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Seroprevalence of HCV and HIV infection among clients of the nation's longest-standing statewide syringe exchange program: A cross-sectional study of Community Health Outreach Work to Prevent AIDS (CHOW).
    Salek TP; Katz AR; Lenze SM; Lusk HM; Li D; Des Jarlais DC
    Int J Drug Policy; 2017 Oct; 48():34-43. PubMed ID: 28779632
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatitis B, hepatitis C and HIV prevalence and related sexual and substance use risk practices among key populations who access HIV prevention, treatment and related services in South Africa: findings from a seven-city cross-sectional survey (2017).
    Scheibe A; Young K; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Puren A; Hausler H
    BMC Infect Dis; 2020 Sep; 20(1):655. PubMed ID: 32894072
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence and associated clinical characteristics of hepatitis B, C, and HIV infections among injecting drug users in Korea.
    Min JA; Yoon Y; Lee HJ; Choi J; Kwon M; Kim K; Lee CU; Kim DJ; Yun H
    J Med Virol; 2013 Apr; 85(4):575-82. PubMed ID: 23364858
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatitis C virus infection among injecting drug users in the Czech Republic -- prevalence and associated factors.
    Zabransky T; Mravcik V; Korcisova B; Rehak V
    Eur Addict Res; 2006; 12(3):151-60. PubMed ID: 16778436
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Demographic determinants of hepatitis C virus seroprevalence among blood donors.
    Murphy EL; Bryzman S; Williams AE; Co-Chien H; Schreiber GB; Ownby HE; Gilcher RO; Kleinman SH; Matijas L; Thomson RA; Nemo GJ
    JAMA; 1996 Apr; 275(13):995-1000. PubMed ID: 8596257
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Seroprevalence of hepatitis B and C in maintenance dialysis in a public hospital in a developing country.
    Otedo AE; Mc'Ligeyo SO; Okoth FA; Kayima JK
    S Afr Med J; 2003 May; 93(5):380-4. PubMed ID: 12830604
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Substance Use Patterns of HIV-Infected Russian Women with and Without Hepatitis C Virus Co-infection.
    Brown JL; DiClemente RJ; Sales JM; Rose ES; Safonova P; Levina OS; Belyakov N; Rassokhin VV
    AIDS Behav; 2016 Oct; 20(10):2398-2407. PubMed ID: 26995679
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Seroprevalence of anti-hepatitis C virus (anti-HCV) antibody and HCV-related risk in injecting drug users in northern India: comparison with non-injecting drug users.
    Basu D; Kumar V; Sharma AK; Barnwal PK; Mattoo SK
    Asian J Psychiatr; 2013 Feb; 6(1):52-5. PubMed ID: 23380318
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatitis C virus seropositivity and the risk factors for transmission among blood donors in some selected centers in Lagos State, Southwest Nigeria.
    Damola AB; Adeniji JA; Bakarey AS
    J Immunoassay Immunochem; 2019; 40(5):528-539. PubMed ID: 31378189
    [No Abstract]   [Full Text] [Related]  

  • 53. Cross-border injection drug use and HIV and hepatitis C virus seropositivity among people who inject drugs in San Diego, California.
    Horyniak D; Wagner KD; Armenta RF; Cuevas-Mota J; Hendrickson E; Garfein RS
    Int J Drug Policy; 2017 Sep; 47():9-17. PubMed ID: 28683432
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence of hepatitis B and C markers in a population of an urban university in Rio de Janeiro, Brazil: a cross-sectional study.
    Pinto FP; Ferreira OC; Olmedo DB; Precioso PM; Barquette FR; Castilho MC; Silva SG; Pôrto LC
    Ann Hepatol; 2015; 14(6):815-25. PubMed ID: 26436353
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatitis A, B and C seroprevalence in Pakistan.
    Agboatwalla M; Isomura S; Miyake K; Yamashita T; Morishita T; Akram DS
    Indian J Pediatr; 1994; 61(5):545-9. PubMed ID: 7538098
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Uptake of hepatitis C treatment among people who inject drugs attending Needle and Syringe Programs in Australia, 1999-2011.
    Iversen J; Grebely J; Topp L; Wand H; Dore G; Maher L
    J Viral Hepat; 2014 Mar; 21(3):198-207. PubMed ID: 24438681
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001.
    Des Jarlais DC; Perlis T; Arasteh K; Torian LV; Hagan H; Beatrice S; Smith L; Wethers J; Milliken J; Mildvan D; Yancovitz S; Friedman SR
    AIDS; 2005 Oct; 19 Suppl 3():S20-5. PubMed ID: 16251819
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Blood-borne virus infections among Australian injecting drug users: implications for spread of HIV.
    Crofts N; Hopper JL; Milner R; Breschkin AM; Bowden DS; Locarnini SA
    Eur J Epidemiol; 1994 Dec; 10(6):687-94. PubMed ID: 7672048
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatitis B and C virus infections among patients with gingivitis and adult periodontitis: seroprevalence and public health importance.
    Farghaly AG; Mansour GA; Mahdy NH; Yousri A
    J Egypt Public Health Assoc; 1998; 73(5-6):707-35. PubMed ID: 17217032
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Community-based seroepidemiological survey of HCV infection in Catalonia, Spain.
    Domínguez A; Bruguera M; Vidal J; Plans P; Salleras L
    J Med Virol; 2001 Dec; 65(4):688-93. PubMed ID: 11745932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.